A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

NCT00269828 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: paclitaxel
DRUG: paclitaxel poliglumex

Sponsor

CTI BioPharma